PT600591E - Inibicao do crescimento de celulas tumorais por administracao de celulas transfectadas com b7 - Google Patents

Inibicao do crescimento de celulas tumorais por administracao de celulas transfectadas com b7

Info

Publication number
PT600591E
PT600591E PT93307816T PT93307816T PT600591E PT 600591 E PT600591 E PT 600591E PT 93307816 T PT93307816 T PT 93307816T PT 93307816 T PT93307816 T PT 93307816T PT 600591 E PT600591 E PT 600591E
Authority
PT
Portugal
Prior art keywords
tumor cells
cells
transfected
tumor
growth
Prior art date
Application number
PT93307816T
Other languages
English (en)
Inventor
Peter S Linsley
Ingegerd Hellstrom
Karl Erik Hellstrom
Jeffrey A Ladbetter
Lieping Chen
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PT600591E publication Critical patent/PT600591E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • A61K39/001102Receptors, cell surface antigens or cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • A61K2039/5156Animal cells expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
PT93307816T 1992-10-02 1993-10-01 Inibicao do crescimento de celulas tumorais por administracao de celulas transfectadas com b7 PT600591E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95612392A 1992-10-02 1992-10-02
US610293A 1993-01-15 1993-01-15

Publications (1)

Publication Number Publication Date
PT600591E true PT600591E (pt) 2003-09-30

Family

ID=26675186

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93307816T PT600591E (pt) 1992-10-02 1993-10-01 Inibicao do crescimento de celulas tumorais por administracao de celulas transfectadas com b7

Country Status (11)

Country Link
US (1) US6183734B1 (pt)
EP (1) EP0600591B1 (pt)
JP (1) JP3837169B2 (pt)
AT (1) ATE239073T1 (pt)
AU (1) AU662450B2 (pt)
CA (1) CA2107537C (pt)
DE (1) DE69332921T2 (pt)
DK (1) DK0600591T3 (pt)
ES (1) ES2197147T3 (pt)
MX (1) MX9306147A (pt)
PT (1) PT600591E (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5056137A (en) * 1989-09-27 1991-10-08 Sills Richard R Method and apparatus for encoding and decoding signals
US5858776A (en) * 1993-11-03 1999-01-12 Repligen Corporation Tumor cells with increased immunogenicity and uses therefor
WO1996021015A2 (en) * 1994-12-30 1996-07-11 Chiron Corporation Combination gene delivery vehicles
CA2172436A1 (en) * 1995-03-23 1996-09-24 Lieping Chen Compositions and methods for increasing the immunogenicity of tumor cells
DE19516040A1 (de) * 1995-05-04 1996-11-07 Boehringer Ingelheim Int Expression TAP und LMP in Tumorzellen
WO1996034952A1 (de) * 1995-05-04 1996-11-07 Boehringer Ingelheim International Gmbh Expression von tap und lmp in tumorzellen
SE9604581D0 (sv) * 1996-12-12 1996-12-12 Karolinska Innovations Ab An agent against cancer and virus infections
US7235653B2 (en) 1996-12-31 2007-06-26 Isis Pharmaceuticals, Inc. Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
US6077833A (en) * 1996-12-31 2000-06-20 Isis Pharmaceuticals, Inc. Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
US6319906B1 (en) 1996-12-31 2001-11-20 Isis Pharmaceuticals Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
US6682741B1 (en) * 1998-06-10 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services β2 microglobulin fusion proteins and high affinity variants
AUPQ755300A0 (en) * 2000-05-17 2000-06-08 Monash University Immune potentiating compositions
US20040136972A1 (en) * 2001-09-07 2004-07-15 Yeda Research And Development Co. Ltd. Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
US20030096016A1 (en) * 2001-09-07 2003-05-22 Yeda Research And Development Co. Ltd. Methods of kidney transplantation utilizing developing nephric tissue
US7780993B2 (en) * 2001-09-07 2010-08-24 Yeda Research And Development Co. Ltd. Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
RU2375077C2 (ru) * 2002-05-02 2009-12-10 Юниверсити Оф Коннектикут Хелт Сентер Использование белков теплового шока для повышения эффективности терапий антителами
IL165425A0 (en) * 2004-11-28 2006-01-15 Yeda Res & Dev Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
CA2463487A1 (en) * 2003-04-28 2004-10-28 Auckland Uniservices Limited Tumours treating combinations, compositions and methods
CA2463464A1 (en) * 2003-04-28 2004-10-28 Auckland Uniservices Limited Methods of treatment and compositions therefor
US7897582B2 (en) 2003-05-23 2011-03-01 Isis Pharmaceuticals, Inc. Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
US7960355B2 (en) 2003-05-23 2011-06-14 Isis Pharmaceuticals, Inc. Compositions and methods for the modulation of the expression of B7 protein

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2086325C (en) * 1990-07-02 2010-10-05 Peter S. Linsley Ligand for cd28 receptor on b cells and methods

Also Published As

Publication number Publication date
EP0600591A3 (en) 1995-03-01
ATE239073T1 (de) 2003-05-15
EP0600591A2 (en) 1994-06-08
DE69332921T2 (de) 2004-05-19
CA2107537A1 (en) 1994-04-03
MX9306147A (es) 1994-06-30
US6183734B1 (en) 2001-02-06
AU4877293A (en) 1994-04-14
JPH0769928A (ja) 1995-03-14
ES2197147T3 (es) 2004-01-01
AU662450B2 (en) 1995-08-31
DK0600591T3 (da) 2003-08-25
EP0600591B1 (en) 2003-05-02
DE69332921D1 (de) 2003-06-05
JP3837169B2 (ja) 2006-10-25
CA2107537C (en) 2007-01-30

Similar Documents

Publication Publication Date Title
PT600591E (pt) Inibicao do crescimento de celulas tumorais por administracao de celulas transfectadas com b7
DE3781786D1 (de) Prothese zum implantieren im hypodermgewebe des urogenitalbereichs.
DE3787717D1 (de) Prothese zum implantieren im hypodermgewebe des urogenitalbereichs.
ATE294864T1 (de) Äusseres membranprotein von haemophilus
HUP9904023A2 (hu) Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban
BR9712556A (pt) Plasmìdeo, composição farmacêutica, e, processo de imunizar um indivìduo contra um antìgeno
DK47286D0 (da) Hundeparvovirus-vacciner
DK246987A (da) Indstillingsmekanisme, isaer til en indstillelig stol
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
PT964697E (pt) Aplicacoes terapeuticas de antigenios ou epitopos, associados com um processamento celular de peptidos deficiente, e.g. expressos em celulas rma-s transfectadas com um gene b7-1
KR890006253A (ko) 가금류내의 E.coli septicaemia에 대한 백신
MA21448A1 (fr) Procede de preparation de structures peptidiques et immunogenes les contenant destines au controle de la fertilite.
KR950700415A (ko) 말라리아 백신(improvements in or relating to malaria vaccine)
MX9206732A (es) Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas de tierra.
AU673344B2 (en) Vaccines based on streptokinase
IT1218692B (it) Procedimento microbiologico per la preparazione di 9 alfa-idrossi-4-androstene-3,17 dione
MX9601071A (es) Composiciones y metodos para incrementar la inmunogenicidad de celulas tumorales.
Samson et al. The kinetics of colicin E3 induced fragmentation of Escherichia coli 16S ribosomal RNA in vivo
AU8501191A (en) Cross-reactive influenza a immunization
Sultanov et al. The properties of deep levels of rhodium in silicon; Svojstva glubokikh urovnej rodiya v kremnii
IT8647546A0 (it) Sistema di infusione transdermica di farmaci nell'area genitale per realizzare, migliorare e/o correggere l'eccitazione sessuale della specie umana
IT8819054A0 (it) Testa di supporto perfezionata per la lavorazione di lastre di vetro, marmo e simili, di qualunque dimensione.
IT218636Z2 (it) Supporto per l'albero rotante di decespugliatori, tagliabordi e simili.
IT8882546A0 (it) Impianto per il trattamento superficiale e l'eventuale accumulo dei prodotti, in particolare diprodotti in legno come serramenti, infissi e simili.
IT8567410A1 (it) Sistema di apertura regolabile dei versoi posteriori e regolazione dell'inclinazione rispetto al piano di lavoro per rincalzatori.